Delivery Order SPE2DB22D2211-SPE2DB24FNLD8
Award Date 5/9/24
Potential Completion Date 5/10/24
Potential Value $5.9K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of Vyvanse 40 mg capsules to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $2,743.20. The contract is a delivery order with a firm fixed price, and the ultimate completion date is June 5, 2024. Amerisourcebergen Drug Corp is a subsidiary of Amerisourcebergen Corporation, one of the largest...
- This federal contract award is for the delivery of Vyvanse 20 mg capsules to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,688.04, is a delivery order awarded under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a potential value of up to $999,999,999 and runs through November 2026. This IDC serves as the primary...
- This federal contract award is for the delivery of Vyvanse 40mg capsules to the Defense Logistics Agency (DLA), a defense agency. The $1,024.00 contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the prescription drug Vyvanse 40mg capsules to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract has a ceiling value of $2,422.08 and is a firm fixed-price delivery order, with a period of performance through July 8, 2024. This award is associated with Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Vyvanse 30 mg capsules. The contract has a firm fixed price, ceiling value of $1,121.72, and a completion date of June 21, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the...
- This federal contract award is for the delivery of 4,566,161,814 capsules of the pharmaceutical product Vyvanse 10 mg to the Defense Logistics Agency (DLA). The $2,741.45 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 18, 2024, with a period of performance through October 21, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
- This federal contract award is for the delivery of 4,564,881,676 units of the prescription drug Vyvanse 30 mg capsules to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD). The contract was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for a ceiling value of $16,404.28. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of June 12,...
- This federal contract award is for the delivery of 4,564,995,521 units of the pharmaceutical drug Vyvanse 40mg capsules to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to the corporate office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on a firm fixed-price basis with a ceiling value of $1,982.22 and a completion date of June 26, 2024. This appears to be a delivery order under a larger...
- This federal contract award is for the delivery of 4,565,099,639 units of the prescription drug Vyvanse (50 mg capsules) to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD). The contract, valued at $2,579.01, was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is a firm fixed-price Delivery Order with a completion date of July 10, 2024. Amerisourcebergen holds several...
- This federal contract award is for the delivery of Vyvanse 60 mg capsules to the Defense Logistics Agency (DLA). The $2,202.34 firm fixed-price delivery order was awarded on October 23, 2024 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of October 24, 2024 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...